Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07357636
What this trial is testing

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Solid TumorImmune-Related Adverse EventsImmunotherapy Toxicity
Shantou University Medical College 940
Large-scale testing (Phase 3)Not Yet RecruitingNCT07790380
What this trial is testing

FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma Who Have Failed Prior PD-1/PD-L1 Inhibitor Combined With Platinum-Based Chemotherapy.

Who this might be right for
Locally Advanced, Recurrent or Metastatic ESCC Patients Who Have Failed Prior PD-1/PD-L1 Inhibitors Combined With Platinum-based Chemotherapy
Jiangsu HengRui Medicine Co., Ltd. 480
Testing effectiveness (Phase 2)Looking for participantsNCT07034391
What this trial is testing

A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status

Who this might be right for
Non-Small Cell Lung Cancer
China Medical University, China 40
Testing effectiveness (Phase 2)Study completedNCT04694183
What this trial is testing

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
Quan Wang 37
Testing effectiveness (Phase 2)Looking for participantsNCT06144671
What this trial is testing

Phase I/II Clinical Study of GT201 Injection as Monotherapy or in Combination With PD-1 Inhibitor for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Grit Biotechnology 78
Post-approval studies (Phase 4)Looking for participantsNCT07744698
What this trial is testing

Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)

Who this might be right for
Squamous Non-Small Cell Lung Cancer sqNSCLCExtensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital 107
Testing effectiveness (Phase 2)Study completedNCT02731729
What this trial is testing

Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy

Who this might be right for
Melanoma
Parker Institute for Cancer Immunotherapy 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05751928
What this trial is testing

Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma (Skin)
Biocad 411
Not applicableStudy completedNCT03868046
What this trial is testing

Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)

Who this might be right for
CancerMetastatic CancerSolid Organ Cancer
Hospital Universitario Araba 242
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747169
What this trial is testing

Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study

Who this might be right for
Squamous Non-Small Cell Lung Cancer SqNSCLC
Jian-Guo Zhou, MD, PhD 32
Testing effectiveness (Phase 2)Looking for participantsNCT05431270
What this trial is testing

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Who this might be right for
Non Small Cell Lung CancerPancreatic Ductal Adenocarcinoma
Phanes Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT04370704
What this trial is testing

Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

Who this might be right for
Melanoma
Incyte Corporation 61
Testing effectiveness (Phase 2)Looking for participantsNCT07387198
What this trial is testing

Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab

Who this might be right for
Merkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage IINeoadjuvant Immunotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 135
Testing effectiveness (Phase 2)UnknownNCT05267366
What this trial is testing

Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC

Who this might be right for
PFSOS
Qingdao Central Hospital 117
Testing effectiveness (Phase 2)UnknownNCT05910034
What this trial is testing

Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Fudan University 132
Testing effectiveness (Phase 2)Looking for participantsNCT06917092
What this trial is testing

QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableUnknownNCT04203095
What this trial is testing

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients

Who this might be right for
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Not applicableLooking for participantsNCT06622031
What this trial is testing

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusSystemic Therapy
Sun Yat-sen University 42
Testing effectiveness (Phase 2)UnknownNCT05549466
What this trial is testing

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 84
Not applicableUnknownNCT04355806
What this trial is testing

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Who this might be right for
Non Small Cell Lung CancerInfluenza Vaccine
Shanghai Pulmonary Hospital, Shanghai, China 160
Next Page